DIRECTORES DEL CURSO:
Dr. Juan Francisco Rodríguez Moreno.
Dr. Jesús García-Donas. Centro Integral Oncológico Clara Campal HM CIOCC
16:00H. – 16:30H. OPENING AND WELCOME.
Dr. Juan Francisco Rodríguez Moreno. Coordinator of Skin Cancer Program HM CIOCC. Dr Jesús García-Donas. Head of Unit: Gynecological, GU and Skin Cancer.
Dr. Antonio Cubillo. Head of Department of Medical Oncology HM CIOCC.
16:30H. - 16:50H. ADJUVANT TREATMENT FOR RESECTED STAGE III AND IV MELANOMA.
Prof. Dr. Dirk Schadendorf. Director & Chair Department of Dermatology & Director Comprehensive Cancer Center. University Hospital Essen.
16:50H. – 17:10H. DISCUSSION.
OPTIONS IN FIRST LINE FOR BRAF MUTANT ADVANCE MELANOMA. 17:10H. – 17:30H. IN FAVOR TARGET THERAPY.
Ana Arance. Department of Medical Oncology. Hospital Clinic Barcelona.
17:30H. – 17:50H. IN FAVOR IMMUNOTHERAPY.
Juan Jesús Martín Liberal. Department of Medical Oncology. Institut Català d'Oncologia.
17:50H. - 18:10H. IMMUNOTHERAPY: WHO NEEDS MORE THAN AN ANTI-PD1?
Prof. Dr. Dirk Schadendorf. Director & Chair Department of Dermatology & Director Comprehensive Cancer Center.
University Hospital Essen.
18:10H. – 18:30H. DISCUSSION.
18:30H. - 18:50H. NEW DRUGS AND FUTURE DEVELOPMENT IN MELANOMA TREATMENT.
Elena Garralda. Executive Director and Principal Investigator of Early Clinical Drug Development Group. VHIO.
18:50H. - 19:10H. MOLECULAR BACKGROUND AND BIOMARKERS IN MELANOMA.
Dr. Juan Francisco Rodríguez-Moreno. Department of Medical Oncology. HM CIOCC.
19:10H. – 19:30H. DISCUSSION. COCKTAIL
Programa Melanoma-22 noviembre.pdf
Inscripciones Gratuitas
Para inscripciones dirigirse a (indicando nombre y dos apellidos):
Secretaria de Docencia HM CIOCC Mª Eugenia Sánchez Doral mesanchez@hmhospitales.com Tfno: 91 756 78 00 – Ext. 4801
Aforo limitado a 232 personas